Literature DB >> 1999252

Mitogenic activity of selenoorganic compounds in human peripheral blood leukocytes.

J A Czyrski1, A D Inglot.   

Abstract

A variety of organoselenium compounds were originally described as antiinflammatory, antioxidant or glutathione-peroxidase-like agents, and as inhibitors of prostaglandin and leukotriene synthesis. Recently, the compounds have also been found to be inducers of interferon gamma and tumor necrosis factor in human peripheral blood leukocytes (PBL). We evaluated the effects of bis [2-(N-phenylcarboxamido)phenyl] diselenide and Ebselen; 2-phenyl-1,2-benzisoselenazol-3(2H)one, on the incorporation of tritiated thymidine into the DNA of PBL cultured in vitro. Both compounds were mitogenic and this effect was correlated with the expression of interleukin 2 receptor in T-lymphocytes. Therefore, we suggest that the selenoorganic compounds may induce mitogenic cytokines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999252     DOI: 10.1007/bf02041265

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  11 in total

1.  Organoselenides as potential immunostimulants and inducers of interferon gamma and other cytokines in human peripheral blood leukocytes.

Authors:  A D Inglot; J Zielińska-Jenczylik; E Piasecki; L Syper; J Młochowski
Journal:  Experientia       Date:  1990-03-15

2.  Production and partial purification of human immune interferon.

Authors:  K Cantell; S Hirvonen; H L Kauppinen
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  A new immunomodulating compound (AS-101) with potential therapeutic application.

Authors:  B Sredni; R R Caspi; A Klein; Y Kalechman; Y Danziger; M Ben Ya'akov; T Tamari; F Shalit; M Albeck
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

4.  A novel biologically active selenooorganic compound--VII. Biotransformation of ebselen in perfused rat liver.

Authors:  A Müller; H Gabriel; H Sies; R Terlinden; H Fischer; A Römer
Journal:  Biochem Pharmacol       Date:  1988-03-15       Impact factor: 5.858

Review 5.  Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions.

Authors:  M J Parnham; E Graf
Journal:  Biochem Pharmacol       Date:  1987-10-01       Impact factor: 5.858

6.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.

Authors:  T Uchiyama; D L Nelson; T A Fleisher; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Interleukin 2 receptor blockade by anti-Tac antibody inhibits IFN-gamma induction.

Authors:  A D Croll; M F Wilkinson; A G Morris
Journal:  Cell Immunol       Date:  1985-04-15       Impact factor: 4.868

8.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

9.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

10.  A novel biologically active selenoorganic compound. VIII. Biotransformation of ebselen.

Authors:  H Fischer; R Terlinden; J P Löhr; A Römer
Journal:  Xenobiotica       Date:  1988-12       Impact factor: 1.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.